Med 7 LLC, announces the completion of a sleep study using Hempzorb81 Full Spectrum Hemp Oil.
Posted: October 1, 2021 at 5:10 p.m. CDT|Update: 4 hours ago
BLUFFDALE, Utah, October 1, 2021 / PRNewswire / – Med 7, LLC (www.med 7cbd.com) and HempCo, Inc. announce the completion of a human clinical study to evaluate the effects of Med 7 on sleep. Med 7 is a full spectrum hemp product made with Purzorb® technology, now registered as Hempzorb81. “More than 30 million Americans suffer from sleep problems affecting work productivity and quality of life,” said Matt smith, CEO of Med 7. “In our first safety and efficacy study of Hempzorb81, 91% of patients on Med 7 reported better sleep and more active dreams. We wanted to take a deep dive and see the effects of Hempzorb81 on sleep cycles and other health measures. ” This study was conducted with support from the National Institutes of Health (NIH) as part of their Small Business Grants program.
In this placebo-controlled study, Hempzorb81 demonstrated an increase in deep sleep over 54 minutes.
In this placebo-controlled study of 150 patients, Hempzorb81 demonstrated a significant effect on increasing deep sleep over 54 minutes compared to placebo. Patients taking Hempzorb81 also had a decrease in wakefulness of more than 18 minutes compared to placebo. Patients were studied using the FitBit® Charge 3 in this 3 month study. Hempzorb81 also had a positive effect on other measures of health and well-being (www.hempzorb81.org).
Patients in this Hempzorb81 study reported no sedation or serious side effects. “Having a fast-acting, non-sedating, safe product to promote better sleep will have a huge effect on the health and well-being of many lives,” said Derrick DeSilva, Jr. MD, director of the Med 7 Medical Advisory Board. “This study reinforces what I have seen for many years with patients in my practice.” Cannabidiol (CBD) alone or in combination with other cannabinoids has had mixed results in sleep studies and has never been studied in a large placebo-controlled study. “One in four Americans develop sleep problems each year. This study should give consumers and healthcare providers confidence that there is a hemp product that contains CBD that is now supported by clinical studies. human. “
About Med 7
Average 7® is a technology-driven health and wellness company that distributes full spectrum hemp based CBD oil products using Purzorb® to healthcare professionals. Purzorb® is a patent pending technology that mimics the body’s natural absorption process by converting oil-based nutrients into water soluble products.
View original content to download multimedia:
The above press release has been provided courtesy of PRNewswire. The views, opinions and statements contained in the press release are not endorsed by Gray Media Group and do not necessarily state or reflect those of Gray Media Group, Inc.